273 related articles for article (PubMed ID: 24865412)
1. Incidence and clinical management of oral human papillomavirus infection in men: a series of key short messages.
Videla S; Darwich L; Cañadas M; Clotet B; Sirera G
Expert Rev Anti Infect Ther; 2014 Aug; 12(8):947-57. PubMed ID: 24865412
[TBL] [Abstract][Full Text] [Related]
2. Cancers attributable to human papillomavirus infection.
Grulich AE; Jin F; Conway EL; Stein AN; Hocking J
Sex Health; 2010 Sep; 7(3):244-52. PubMed ID: 20719211
[TBL] [Abstract][Full Text] [Related]
3. The prevalence and incidence of oral human papillomavirus infection among young men and women, aged 18-30 years.
Pickard RK; Xiao W; Broutian TR; He X; Gillison ML
Sex Transm Dis; 2012 Jul; 39(7):559-66. PubMed ID: 22706220
[TBL] [Abstract][Full Text] [Related]
4. [Human papilloma virus in head and neck cancer].
Barry B; Ortholan C
Cancer Radiother; 2014 Oct; 18(5-6):430-3. PubMed ID: 25151649
[TBL] [Abstract][Full Text] [Related]
5. Understanding personal risk of oropharyngeal cancer: risk-groups for oncogenic oral HPV infection and oropharyngeal cancer.
D'Souza G; McNeel TS; Fakhry C
Ann Oncol; 2017 Dec; 28(12):3065-3069. PubMed ID: 29059337
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus in cervical cancer and oropharyngeal cancer: One cause, two diseases.
Berman TA; Schiller JT
Cancer; 2017 Jun; 123(12):2219-2229. PubMed ID: 28346680
[TBL] [Abstract][Full Text] [Related]
7. Incidence and clearance of oral human papillomavirus infection in men: the HIM cohort study.
Kreimer AR; Pierce Campbell CM; Lin HY; Fulp W; Papenfuss MR; Abrahamsen M; Hildesheim A; Villa LL; Salmerón JJ; Lazcano-Ponce E; Giuliano AR
Lancet; 2013 Sep; 382(9895):877-87. PubMed ID: 23827089
[TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus prevalence and prognostic implication in oropharyngeal squamous cell carcinomas.
Melkane AE; Auperin A; Saulnier P; Lacroix L; Vielh P; Casiraghi O; Msakni I; Drusch F; Temam S
Head Neck; 2014 Feb; 36(2):257-65. PubMed ID: 23728782
[TBL] [Abstract][Full Text] [Related]
9. Oncogenic impact of human papilloma virus in head and neck cancer.
Heffernan CB; O'Neill JP; Timon C
J Laryngol Otol; 2010 Sep; 124(9):941-4. PubMed ID: 20519038
[TBL] [Abstract][Full Text] [Related]
10. Sex Differences in Risk Factors and Natural History of Oral Human Papillomavirus Infection.
D'Souza G; Wentz A; Kluz N; Zhang Y; Sugar E; Youngfellow RM; Guo Y; Xiao W; Gillison ML
J Infect Dis; 2016 Jun; 213(12):1893-6. PubMed ID: 26908748
[TBL] [Abstract][Full Text] [Related]
11. The incidence, clearance and persistence of non-cervical human papillomavirus infections: a systematic review of the literature.
Taylor S; Bunge E; Bakker M; Castellsagué X
BMC Infect Dis; 2016 Jun; 16():293. PubMed ID: 27301867
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and characteristics of HPV infection in oropharyngeal cancer.
De Stefani A; Boffano P; Averono G; Ramella A; Pia F; Bongioannini G
J Craniofac Surg; 2013 Jan; 24(1):e40-3. PubMed ID: 23348332
[TBL] [Abstract][Full Text] [Related]
13. Beyond cervical cancer: burden of other HPV-related cancers among men and women.
Chaturvedi AK
J Adolesc Health; 2010 Apr; 46(4 Suppl):S20-6. PubMed ID: 20307840
[TBL] [Abstract][Full Text] [Related]
14. NHANES 2009-2012 Findings: Association of Sexual Behaviors with Higher Prevalence of Oral Oncogenic Human Papillomavirus Infections in U.S. Men.
Chaturvedi AK; Graubard BI; Broutian T; Pickard RK; Tong ZY; Xiao W; Kahle L; Gillison ML
Cancer Res; 2015 Jun; 75(12):2468-77. PubMed ID: 25873485
[TBL] [Abstract][Full Text] [Related]
15. Could the human papillomavirus vaccination be cost-effective in males for the prevention of oropharyngeal cancer?
Isaranuwatchai W; Graham DM; Siu LL; Hoch JS
Expert Rev Pharmacoecon Outcomes Res; 2014 Dec; 14(6):763-5. PubMed ID: 25095728
[TBL] [Abstract][Full Text] [Related]
16. Oral HPV infection: current strategies for prevention and therapy.
Syrjanen S; Termine N; Capra G; Paderni C; Panzarella V; Campisi G
Curr Pharm Des; 2012; 18(34):5452-69. PubMed ID: 22632393
[TBL] [Abstract][Full Text] [Related]
17. National prevalence of oral HPV infection and related risk factors in the U.S. adult population.
Sanders AE; Slade GD; Patton LL
Oral Dis; 2012 Jul; 18(5):430-41. PubMed ID: 22251072
[TBL] [Abstract][Full Text] [Related]
18. Squamous cell carcinoma metastatic to neck from an unknown primary: the potential impact of modern pathologic evaluation on perceived incidence of human papillomavirus-positive oropharyngeal carcinoma prior to 1970.
Chenevert J; Seethala RR; Barnes EL; Chiosea SI
Laryngoscope; 2012 Apr; 122(4):793-6. PubMed ID: 22252715
[TBL] [Abstract][Full Text] [Related]
19. Oropharyngeal squamous cell carcinoma and human papillomavirus-associated cancers in women: epidemiologic evaluation of association.
Biron VL; Côté DW; Seikaly H
J Otolaryngol Head Neck Surg; 2011 Feb; 40 Suppl 1():S65-9. PubMed ID: 21453664
[TBL] [Abstract][Full Text] [Related]
20. Natural history of human papillomavirus infections involving anal, penile, and oral sites among HIV-positive men.
Videla S; Darwich L; Cañadas MP; Coll J; Piñol M; García-Cuyás F; Molina-Lopez RA; Cobarsi P; Clotet B; Sirera G;
Sex Transm Dis; 2013 Jan; 40(1):3-10. PubMed ID: 23250297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
